Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health


Personal tools

You are here: Home / Biomarkers / EPB41L3



This biomarker is also known as:
  • DAL1,
  • erythrocyte membrane protein band 4.1-like 3,
  • differentially expressed in adenocarcinoma of the lung protein 1,
  • DAL-1,
  • band 4.1-like protein 3,
  • Q9Y2J2,
  • 4.1B,
  • Differentially expressed in adenocarcinoma of the lung protein 1,
  • KIAA0987,

View in BioMuta


EPB41L3 protein is a critical growth regulator in the pathogenesis of meningiomas. There are three isoforms of this protein, produced by alternative splicing.


QA State: Curated
Type: Protein
Short Name:
HGNC Name: EPB41L3


There are no datasets associated with this biomarker.


The following organs have data associated with this biomarker…



Phase: Two
QA State: Under Review


EPB41L3 has been identified as a functional suppressor of epithelial ovarian cancers.

Performance Comment

EPB41L3 was one of 50 tumor vasculature-associated genes with transmembrane or secreted protein products identified through expression profiling of ovarian cancer vascular cells. These 50 tumor vascular markers (TVMs) also had low or no expression in normal tissues. EPB41L3 was not in the group of 13 selected for further validation.


This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at if you should have access to this biomarker.

2016 EDRN PI Orientation

The New and Continuing EDRN Principal Investigator Orientation will take place March 14–15, 2016 in Bethesda, Maryland.

Announcement 11/05/2015

Thank you to everyone who made the 29th EDRN Steering Committee Meeting a success. The orientation for new and continuing EDRN PIs will be held Monday-Tuesday, March 14-15, 2016, on the NCI campus. More information will be available later this autumn.

Announcement 06/30/2015

A funding opportunity for a new pancreatic cancer initiative, called The Pancreatic Cancer Detection Consortium (U01), has been released. For more information, please go to /grants/guide/ pa-files/ PAR-15-289.html.